cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.30911498
title: Supplementary Material for: Combined Effects of Pulmonary Hypertension and Heart Valve Calcification on Cardiovascular Outcomes in Maintenance Hemodialysis Patients: A Risk Stratification Study Using Echocardiography

description: Background: Cardiovascular disease remains the leading cause of mortality in maintenance hemodialysis (MHD) patients. While both pulmonary hypertension (PH) and heart valve calcification (HVC) are established independent risk factors for adverse outcomes in this population, the synergistic effect of these two echocardiographic parameters on cardiovascular prognosis has not been well investigated.
Methods: In this prospective study, we analyzed clinical and echocardiographic data from 302 MHD patients over a two-year follow-up period. Patients were stratified into three groups based on the presence of risk factors: group 1 (no risk factors), group 2 (either PH or HVC), and group 3 (both PH and HVC). Survival analysis was performed using Kaplan-Meier curves, and Cox regression models were employed to evaluate the impact on all-cause mortality, cardiovascular mortality, and new-onset cardiovascular events (CV events).
Results: During follow-up, 63 patients (20.9%) died from all causes, with 36 deaths (57.1%) attributed to CV events. Cardiovascular mortality was significantly higher in Groups 2 (13.2%) and 3 (30.2%) compared to Group 1 (5.1%; p&lt;0.001). New-onset CV events occurred in 33.1% of patients, with rates of 20.3%, 35.5%, and 67.4% in Groups 1, 2 and 3, respectively (p&lt;0.001). The presence of both PH and HVC was associated with a higher risk of all-cause mortality, cardiovascular mortality, and new-onset CV events compared to either PH or HVC alone. After adjusting for confounders, the combination of PH and HVC remained a significant predictor, demonstrating a higher risk than having a single risk factor [HR for all-cause mortality: 3.76 (95% CI: 1.83-7.73) vs. 1.90 (95% CI: 1.03-3.52); HR for cardiovascular mortality: 9.23 (95% CI: 3.42-24.95) vs. 3.11 (95% CI: 1.23-7.84); HR for new-onset CV events: 4.21 (95% CI: 2.39-7.21) vs. 1.68 (95% CI:1.01-2.76)].
Conclusions: The coexistence of PH and HVC significantly increases cardiovascular risk compared to either condition alone in MHD patients. Echocardiography is a valuable tool for screening and risk stratification in this high-risk population by identifying both PH and HVC.
DOI: 10.6084/m9.figshare.30911498.v1
title: Supplementary Material for: Combined Effects of Pulmonary Hypertension and Heart Valve Calcification on Cardiovascular Outcomes in Maintenance Hemodialysis Patients: A Risk Stratification Study Using Echocardiography

description: Background: Cardiovascular disease remains the leading cause of mortality in maintenance hemodialysis (MHD) patients. While both pulmonary hypertension (PH) and heart valve calcification (HVC) are established independent risk factors for adverse outcomes in this population, the synergistic effect of these two echocardiographic parameters on cardiovascular prognosis has not been well investigated.
Methods: In this prospective study, we analyzed clinical and echocardiographic data from 302 MHD patients over a two-year follow-up period. Patients were stratified into three groups based on the presence of risk factors: group 1 (no risk factors), group 2 (either PH or HVC), and group 3 (both PH and HVC). Survival analysis was performed using Kaplan-Meier curves, and Cox regression models were employed to evaluate the impact on all-cause mortality, cardiovascular mortality, and new-onset cardiovascular events (CV events).
Results: During follow-up, 63 patients (20.9%) died from all causes, with 36 deaths (57.1%) attributed to CV events. Cardiovascular mortality was significantly higher in Groups 2 (13.2%) and 3 (30.2%) compared to Group 1 (5.1%; p&lt;0.001). New-onset CV events occurred in 33.1% of patients, with rates of 20.3%, 35.5%, and 67.4% in Groups 1, 2 and 3, respectively (p&lt;0.001). The presence of both PH and HVC was associated with a higher risk of all-cause mortality, cardiovascular mortality, and new-onset CV events compared to either PH or HVC alone. After adjusting for confounders, the combination of PH and HVC remained a significant predictor, demonstrating a higher risk than having a single risk factor [HR for all-cause mortality: 3.76 (95% CI: 1.83-7.73) vs. 1.90 (95% CI: 1.03-3.52); HR for cardiovascular mortality: 9.23 (95% CI: 3.42-24.95) vs. 3.11 (95% CI: 1.23-7.84); HR for new-onset CV events: 4.21 (95% CI: 2.39-7.21) vs. 1.68 (95% CI:1.01-2.76)].
Conclusions: The coexistence of PH and HVC significantly increases cardiovascular risk compared to either condition alone in MHD patients. Echocardiography is a valuable tool for screening and risk stratification in this high-risk population by identifying both PH and HVC.
DOI: 10.6084/m9.figshare.30911501
title: Supplementary Material for: Successful Living Kidney Donation from Heterozygous Carrier Parents to Siblings with Coenzyme Q8B Nephropathy: Two Case Series

description: Introduction:
Coenzyme Q8B (COQ8B) nephropathy is an autosomal recessive hereditary disorder caused by primary coenzyme Q10 (CoQ10) deficiency. It manifests as a genetic steroid-resistant nephrotic syndrome (SRNS), typically of childhood-onset. CoQ10 supplementation is a treatment option; however, it is not always effective in an entire patient population, leading to end-stage kidney disease. Kidney transplantation (KTx) is an effective treatment option for genetic SRNS; however, living KTx within biologically related members is associated with increased risk of allograft failure in recipients and future kidney dysfunction in donors. Here, we present two successful cases of living kidney donations from heterozygous carrier parents to their siblings with COQ8B nephropathy. 

Case presentation:
The family comprised two parents and three siblings. Two of the daughters were diagnosed with proteinuria at 11 and 8 years of age, respectively. COQ8B nephropathy diagnosis was confirmed by next-generation and Sanger sequencing analysis, which revealed a novel compound heterozygous mutation in the COQ8B gene (c.737G&gt;A and c.1468C&gt;T). An older sister missed an opportunity for CoQ10 supplementation due to late diagnosis, whereas a younger sister did not respond to CoQ10 supplementation. Living kidney donation from father to the older sister and from mother to the younger sister was successfully performed without posttransplant recurrence in recipients or kidney dysfunction in donors within 5 and 2 years of follow-up. 

Conclusion:
Parent-to-child KTx may be an effective treatment option within family members affected with COQ8B nephropathy.
DOI: 10.6084/m9.figshare.30911501.v1
title: Supplementary Material for: Successful Living Kidney Donation from Heterozygous Carrier Parents to Siblings with Coenzyme Q8B Nephropathy: Two Case Series

description: Introduction:
Coenzyme Q8B (COQ8B) nephropathy is an autosomal recessive hereditary disorder caused by primary coenzyme Q10 (CoQ10) deficiency. It manifests as a genetic steroid-resistant nephrotic syndrome (SRNS), typically of childhood-onset. CoQ10 supplementation is a treatment option; however, it is not always effective in an entire patient population, leading to end-stage kidney disease. Kidney transplantation (KTx) is an effective treatment option for genetic SRNS; however, living KTx within biologically related members is associated with increased risk of allograft failure in recipients and future kidney dysfunction in donors. Here, we present two successful cases of living kidney donations from heterozygous carrier parents to their siblings with COQ8B nephropathy. 

Case presentation:
The family comprised two parents and three siblings. Two of the daughters were diagnosed with proteinuria at 11 and 8 years of age, respectively. COQ8B nephropathy diagnosis was confirmed by next-generation and Sanger sequencing analysis, which revealed a novel compound heterozygous mutation in the COQ8B gene (c.737G&gt;A and c.1468C&gt;T). An older sister missed an opportunity for CoQ10 supplementation due to late diagnosis, whereas a younger sister did not respond to CoQ10 supplementation. Living kidney donation from father to the older sister and from mother to the younger sister was successfully performed without posttransplant recurrence in recipients or kidney dysfunction in donors within 5 and 2 years of follow-up. 

Conclusion:
Parent-to-child KTx may be an effective treatment option within family members affected with COQ8B nephropathy.
DOI: 10.57760/sciencedb.j00113.00046
title: The data of "Transverse manipulation of particles using Bessel beam of tunable size generated by XPM "
title: The data of "Transverse manipulation of particles using Bessel beam of tunable size generated by XPM "

description: The data related to the article "Transverse manipulation of particles using Bessel beam of tunable size generated by XPM " was published in the journal of Chinese Physics B. It contains an Excel file and two videos, which are described below:

The calculated capture feature of the polystyrene particles studied in the article, including the radial capture force (Fρ) ; the potential.
The video (The trapping of particles) shows a typical process of capturing polystyrene particles in a Bessel beam.
The video (The manipulation of particles) shows a typical process for the manipulation of trapped polystyrene particles in Bessel beams of different sizes
description: The data related to the article "Transverse manipulation of particles using Bessel beam of tunable size generated by XPM " was published in the journal of Chinese Physics B. It contains an Excel file and two videos, which are described below:

The calculated capture feature of the polystyrene particles studied in the article, including the radial capture force (Fρ) ; the potential.
The video (The trapping of particles) shows a typical process of capturing polystyrene particles in a Bessel beam.
The video (The manipulation of particles) shows a typical process for the manipulation of trapped polystyrene particles in Bessel beams of different sizes
DOI: 10.6084/m9.figshare.30911504
title: Supplementary Material for: Comparative Real-World Efficacy of Anti-VEGF Agents in Neovascular AMD: A Multicenter Retrospective Study

description: Introduction: This study directly compared the real-world effectiveness of bevacizumab, aflibercept 2 mg, and ranibizumab as first-line treatments for neovascular age-related macular degeneration (nvAMD). 
Methods: Multicenter retrospective cohort of treatment-naïve nvAMD eyes managed with a treat-and-extend regimen in Israel and Canada. Primary outcomes were changes in visual acuity (VA) and central retinal thickness (CRT). Secondary outcomes included treatment burden (total injections and final maintained interval), non-response (persistent/worsening exudation or functional decline despite adequate treatment), non-extension (final interval of 4 weeks), and absence of active exudation. 
Results: A total of 322 eyes received bevacizumab (n=174), aflibercept (n=110), or ranibizumab (n=38) over a mean follow-up of 16.75 ± 12.66 months. Mean VA improved from 0.77 ± 0.47 to 0.60 ± 0.45 logMAR following an average of 10.5 ± 6.3 injections. Aflibercept produced greater CRT reduction (-51.94 μm; p&lt;0.001), fewer injections (-2.35; p=0.001), longer final intervals (+2.14 weeks; p&lt;0.001), and lower odds of non-response (aOR 0.016; p&lt;0.001) and non-extension (aOR 0.128, p&lt;0.001) versus bevacizumab. It showed the largest mean VA gain, just short of significance on multivariable analysis (p=0.059). Ranibizumab showed greater CRT reduction (-44.53 μm; p=0.012) and lower non-extension odds (aOR 0.079; p=0.001) than bevacizumab, but did not significantly reduce treatment burden or improve VA. 
Conclusion: In this first real-world, head-to-head comparison, aflibercept and ranibizumab outperformed bevacizumab in key anatomic and treatment-efficiency outcomes, with aflibercept showing the most consistent advantages. These findings highlight clinically relevant differences among anti-VEGF agents and underscore the importance of real-world data to guide nvAMD management.
DOI: 10.6084/m9.figshare.30911504.v1
title: Supplementary Material for: Comparative Real-World Efficacy of Anti-VEGF Agents in Neovascular AMD: A Multicenter Retrospective Study

description: Introduction: This study directly compared the real-world effectiveness of bevacizumab, aflibercept 2 mg, and ranibizumab as first-line treatments for neovascular age-related macular degeneration (nvAMD). 
Methods: Multicenter retrospective cohort of treatment-naïve nvAMD eyes managed with a treat-and-extend regimen in Israel and Canada. Primary outcomes were changes in visual acuity (VA) and central retinal thickness (CRT). Secondary outcomes included treatment burden (total injections and final maintained interval), non-response (persistent/worsening exudation or functional decline despite adequate treatment), non-extension (final interval of 4 weeks), and absence of active exudation. 
Results: A total of 322 eyes received bevacizumab (n=174), aflibercept (n=110), or ranibizumab (n=38) over a mean follow-up of 16.75 ± 12.66 months. Mean VA improved from 0.77 ± 0.47 to 0.60 ± 0.45 logMAR following an average of 10.5 ± 6.3 injections. Aflibercept produced greater CRT reduction (-51.94 μm; p&lt;0.001), fewer injections (-2.35; p=0.001), longer final intervals (+2.14 weeks; p&lt;0.001), and lower odds of non-response (aOR 0.016; p&lt;0.001) and non-extension (aOR 0.128, p&lt;0.001) versus bevacizumab. It showed the largest mean VA gain, just short of significance on multivariable analysis (p=0.059). Ranibizumab showed greater CRT reduction (-44.53 μm; p=0.012) and lower non-extension odds (aOR 0.079; p=0.001) than bevacizumab, but did not significantly reduce treatment burden or improve VA. 
Conclusion: In this first real-world, head-to-head comparison, aflibercept and ranibizumab outperformed bevacizumab in key anatomic and treatment-efficiency outcomes, with aflibercept showing the most consistent advantages. These findings highlight clinically relevant differences among anti-VEGF agents and underscore the importance of real-world data to guide nvAMD management.
DOI: 10.5281/zenodo.17973417
title: Global marine photosynthesis parameters dateset

description: This dataset is a collection of marine photosynthesis-irradiance parameters, namely the initial slope and assimilation number, gathered globally from 1958 to 2017. These parameters describe the linear response of primary production under low light conditions and the rate of primary production at saturating light intensities, respectively, and are crucial for any model of watercolumn primary production. The parameters are obtained using inverse modelling approach applied to depth-resolved 14C primary productivity measurements, chlorophyll a vertical concentration profiles as proxies to biomass, attenuation coefficients and noon irradiance and daylight variables. The set successfully retrieved more than 4100 pairs of photosynthesis-irradiance parameters, and, as such, doubles the amount of publicly-available parameters, which opens the avenue for novel research direction of primary production.

 
description: In order of appearance, the columns are:

ID of profile

Date (YYYY-MM-DD) of profile

Latitude (decimal degree) of profile

Longitude (decimal degree) of profile

Assimilation number (mg C (mg Chl)^-1 h^-1)

Inital slope (mg C (mg Chl)^-1 (W m^-2 )^-1 h^-1

Inital slope FLAG (0 if inital slope is missing, 0.5 if initial slope is greater than 0.5 and 1 otherwise)
DOI: 10.5281/zenodo.17973416
title: Global marine photosynthesis parameters dateset

description: This dataset is a collection of marine photosynthesis-irradiance parameters, namely the initial slope and assimilation number, gathered globally from 1958 to 2017. These parameters describe the linear response of primary production under low light conditions and the rate of primary production at saturating light intensities, respectively, and are crucial for any model of watercolumn primary production. The parameters are obtained using inverse modelling approach applied to depth-resolved 14C primary productivity measurements, chlorophyll a vertical concentration profiles as proxies to biomass, attenuation coefficients and noon irradiance and daylight variables. The set successfully retrieved more than 4100 pairs of photosynthesis-irradiance parameters, and, as such, doubles the amount of publicly-available parameters, which opens the avenue for novel research direction of primary production.

 
description: In order of appearance, the columns are:

ID of profile

Date (YYYY-MM-DD) of profile

Latitude (decimal degree) of profile

Longitude (decimal degree) of profile

Assimilation number (mg C (mg Chl)^-1 h^-1)

Inital slope (mg C (mg Chl)^-1 (W m^-2 )^-1 h^-1

Inital slope FLAG (0 if inital slope is missing, 0.5 if initial slope is greater than 0.5 and 1 otherwise)
DOI: 10.3535/2q3-5ka-066
title: Cerastis rubricosa [Denis & Schiffermüller], 1775

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/8tr-qzr-cza
title: Photedes minima Haworth, 1809

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/wjc-vee-hfs
title: Protolampra sobrina Duponchel, 1843

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/weg-2jc-q8c
title: Xanthia (Cirrhia) Hübner, 1816

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/fy4-hxx-b8f
title: Brachionycha nubeculosa Esper, 1785

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/g1e-2de-khq
title: Amphipoea Billberg, 1820

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/ll9-d9d-db7
title: Cerastis rubricosa [Denis & Schiffermüller], 1775

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.15468/dl.mq722z
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{"type":"and","predicates":[{"type":"within","geometry":"POLYGON ((70.727341 30.331437, 70.64600900000001 30.325859, 70.56670699999999 30.309264, 70.491411 30.282067, 70.421995 30.244944, 70.360179 30.198822, 70.307491 30.144846, 70.26522199999999 30.084358, 70.23440100000001 30.018857, 70.215767 29.949963, 70.209756 29.879379, 70.216487 29.808844, 70.23577 29.740092, 70.267107 29.674812, 70.30970600000001 29.614602, 70.362509 29.560936, 70.42421 29.515122, 70.493296 29.478278, 70.568076 29.451302, 70.64672899999999 29.434849, 70.727341 29.42932, 70.807953 29.434849, 70.886606 29.451302, 70.961386 29.478278, 71.030472 29.515122, 71.092173 29.560936, 71.144976 29.614602, 71.187575 29.674812, 71.218912 29.740092, 71.238195 29.808844, 71.24492600000001 29.879379, 71.23891500000001 29.949963, 71.220281 30.018857, 71.18946 30.084358, 71.14719100000001 30.144846, 71.094503 30.198822, 71.032687 30.244944, 70.96327100000001 30.282067, 70.887975 30.309264, 70.808673 30.325859, 70.727341 30.331437))"},{"type":"equals","key":"CLASS_KEY","value":"212","matchCase":false},{"type":"greaterThanOrEquals","key":"YEAR","value":"2015","matchCase":false},{"type":"not","predicate":{"type":"in","key":"BASIS_OF_RECORD","values":["MATERIAL_CITATION","MATERIAL_SAMPLE","PRESERVED_SPECIMEN"],"matchCase":false}},{"type":"lessThanOrEquals","key":"COORDINATE_UNCERTAINTY_IN_METERS","value":"10000","matchCase":false},{"type":"equals","key":"LICENSE","value":"CC BY 4.0","matchCase":false}]}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0058071-251120083545085/datasets/export for details.
DOI: 10.3535/ye4-sbb-t53
title: Eudonia truncicolella (Stainton, 1849)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.15468/dl.e3h2f3
title: Occurrence Download

description: A dataset containing 60827 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Germany",
 "Geometry POLYGON((8.71199 47.62493,9.707 47.679,9.707 47.904,8.706 47.904,8.71199 47.62493))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Arthropoda"
 ]
}

 The dataset includes 60827 records from 91 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0058052-251120083545085/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.3535/dsb-efn-935
title: Sympistis Hübner, 1823

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/ltb-044-8yy
title: Diaphora mendica (Clerck, 1759)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/mx7-fx9-dsd
title: Plusia festucae (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/dm1-yw4-5mv
title: Amphipyra (Amphipyra) perflua (Fabricius, 1787)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/93m-k39-56f
title: Xanthia (Cirrhia) Hübner, 1816

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/vtk-dlp-v4f
title: Sympistis lapponica Thunberg, 1791

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/8x0-k6k-dcs
title: Aglais urticae (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/f43-rf8-6yw
title: Ochropacha duplaris (Linnaeus, 1761)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/131-pt2-m2c
title: Parascotia fuliginaria (Linnaeus, 1761)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/waj-qde-dbd
title: Xylena (Lithomoia) solidaginis Hübner, 1803

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/82l-xa9-qra
title: Oligia Hübner, 1821

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/n9n-hjc-sl2
title: Leucania (Leucania) comma Linnaeus, 1761

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/pk5-zfb-ndg
title: Mythimna (Mythimna) conigera [Denis & Schiffermüller], 1775

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/rz8-h1r-jpp
title: Leucania (Leucania) comma Linnaeus, 1761

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/vdh-zql-kw8
title: Oligia Hübner, 1821

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/jr7-mh9-d12
title: Pyla fusca Haworth, 1811

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/kty-zxk-451
title: Cucullia gnaphalii (Hübner, 1813)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/j09-151-40g
title: Hydraecia micacea Esper, 1789

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/ydc-pam-qly
title: Sympistis lapponica Thunberg, 1791

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.
DOI: 10.3535/088-v8d-e7j
title: Acronicta (Hyboma) strigosa ([Denis & Schiffermüller], 1775)

description: Digital Specimen for the physical specimen hosted at Finnish Museum of Natural History.